Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine-Reference-Cited by-同舟云学术

Development of a lipoplex-type mRNA carrier composed of an ionizable lipid with a vitamin E scaffold and the KALA peptide for use as an ex vivo dendritic cell-based cancer vaccine

Published:2019-09 Issue: Volume:310 Page:36-46
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Tateshita Naho,Miura Naoya,Tanaka Hiroki,Masuda Takeshi,Ohtsuki Sumio^ORCID,Tange Kota,Nakai Yuta,Yoshioka Hiroki,Akita Hidetaka^ORCID

Funder

JSPS KAKENHI

Inohana Foundation

Chiba university

JST CREST

Asahi Glass Foundation

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference35 articles.

1. Dendritic cells and the control of immunity;Banchereau;Nature,1998

2. Antigen presentation and T cell stimulation by dendritic cells;Guermonprez;Annu. Rev. Immunol.,2002

3. Enhancement of dendritic cells as vaccines for cancer;Turnis;Immunotherapy,2010

4. Clinical use of dendritic cells for cancer therapy;Anguille;Lancet Oncol.,2014

5. Diversity and collaboration for effective immunotherapy;Palucka;Nat. Med.,2016

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Self-modifying NanoEnhancers facilitating lysosomal escape for cGAS-STING cascading activation in tumor immunotherapy;Nano Today;2024-08

2. Dysfunction of dendritic cells in tumor microenvironment and immunotherapy;Cancer Communications;2024-07-25

3. Advancing mRNA Therapeutics: The Role and Future of Nanoparticle Delivery Systems;Molecular Pharmaceutics;2024-07-02

4. An overview of lipid constituents in lipid nanoparticle mRNA delivery systems;WIREs Nanomedicine and Nanobiotechnology;2024-07

5. Involvement of miR-199a-5p-loaded mesoporous silica nanoparticle-polyethyleneimine-KALA in osteogenic differentiation;Journal of Dental Sciences;2024-07